Y. Tamimi

发表

Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid.

John Tulip, Zhengwen Xiao, J. Tulip, 2002, Urologic oncology.

Screening for Anti-Cancer Compounds in Marine Organisms in Oman.

S. Dobretsov, Y. Tamimi, M. Al-Kindi, 2016, Sultan Qaboos University medical journal.

A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.

H. G. van der Poel, J. Schalken, F. Debruyne, 1996, British Journal of Cancer.

Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.

H. G. van der Poel, J. Schalken, F. Debruyne, 1993, Cancer research.

BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes

Allal Ouhtit, A. Ouhtit, I. Gupta, 2017, Endocrine connections.

BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes

A. Ouhtit, I. Gupta, Y. Tamimi, 2017, Endocrine connections.

WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis.

P. Grundy, Y. Tamimi, Usukuma Ekuere, 2008, Neoplasia.

FGF19 is a target for FOXC1 regulation in ciliary body-derived cells.

M. Walter, F. Berry, Y. Tamimi, 2006, Human molecular genetics.

Paired box genes, PAX-2 and PAX-8, are not frequently mutated in Wilms tumor.

P. Grundy, K. Stone, Y. Tamimi, 2006, Mutation research.

HLADRB1 Gene is Highly Mutated in Omani Patients Affected with Rheumatoid Arthritis

I. Gupta, Y. Tamimi, B. Hassan, 2015 .

Addition of Gallic Acid Overcomes Resistance to Cisplatin in Ovarian Cancer Cell Lines

B. Tsang, S. Dobretsov, Y. Tamimi, 2022, Asian Pacific journal of cancer prevention : APJCP.

Leiomyosarcoma of the Bladder in a Retinoblastoma Patient

R. Godbout, S. Bléoo, Ronald B. Moore, 2003, Urologia Internationalis.

p16 mutations/deletions are not frequent events in prostate cancer.

J. Schalken, A. van Bokhoven, P. Bringuier, 1996, British Journal of Cancer.

SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer

I. Gupta, Y. Tamimi, M. Al Moundhri, 2022, Human Cell.

Selective cytotoxicity of gemcitabine in bladder cancer cell lines

Y. Tamimi, S. Karmali, K.K. Wong, 2002, Anti-cancer drugs.

Identification and validation of a novel long non-coding RNA (LINC01465) in ovarian cancer

A. Okamoto, I. Gupta, Y. Tamimi, 2022, Human Cell.

Identification of target genes regulated by FOXC1 using nickel agarose-based chromatin enrichment.

M. Walter, Y. Tamimi, M. Lines, 2004, Investigative ophthalmology & visual science.

Identification of a minimal region of loss on the short arm of chromosome 1 in Wilms tumor

P. Grundy, Y. Tamimi, K. Dietrich, 2007, Genes, chromosomes & cancer.

Hoxb13, a potential prognostic biomarker for prostate cancer.

A. Ouhtit, I. Gupta, Y. Tamimi, 2016, Frontiers in bioscience.

Micrometastatic Circulating Tumor cells - A Challenge for an Early Detection and Better Survival Rates

I. Gupta, Y. Tamimi, I. Burney, 2015 .

Homozygous deletions of p16INK4 occur frequently in bilharziasis‐associated bladder cancer

J. Schalken, A. van Bokhoven, F. Debruyne, 1996, International journal of cancer.

FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer

A. Okamoto, Y. Tamimi, I. Burney, 2020, BMC Cancer.

Molecular genetics complexity impeding research progress in breast and ovarian cancers

I. Gupta, Y. Tamimi, I. Burney, 2017, Molecular and clinical oncology.

Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.

E. Schuuring, J. Schalken, P. Bringuier, 1996, Oncogene.

The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis.

M. Walter, O. Lehmann, F. Berry, 2005, Human molecular genetics.

Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis

B. Tsang, S. Dobretsov, Y. Tamimi, 2021, Molecules.

FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer

A. Okamoto, Y. Tamimi, I. Burney, 2020, BMC Cancer.

Selective reovirus killing of bladder cancer in a co-culture spheroid model.

Ronald B. Moore, Y. Tamimi, S. Karmali, 2003, Virus research.

Exosomes as crucial emerging tools for intercellular communication with therapeutic potential in ovarian cancer

Y. Tamimi, Shika Hanif Malgundkar, S. Malgundkar, 2023, Future science OA.

Hymenialdisine is Cytotoxic Against Cisplatin-Sensitive but Not Against Cisplatin-Resistant Cell Lines

Y. Tamimi, I. Burney, Sergey Dobretsov, 2021, Sultan Qaboos University Medical Journal.

Biochemical Analysis of the Differential Tissue Expression of Heat Shock Protein70 Following Exposure to Electromagnetic

Najam A. Siddiqi, Y. Tamimi, Zoya Sheikh, 2021 .

Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma.

G. Jakse, Y. Tamimi, P. Effert, 2004, Anticancer research.

Understanding the functional discrepancy of Pim-1 in cancer.

A. Ouhtit, I. Gupta, Y. Tamimi, 2015, Frontiers in bioscience.

A novel missense mutation in the C2C domain of otoferlin causes profound hearing impairment in an Omani family with auditory neuropathy

Y. Tamimi, G. Van Camp, M. Al-Kindi, 2016, Saudi medical journal.

Antioxidant and Antitumor Properties of Wild Blueberry (Sideroxylon mascatense): Effects of Drying Methods

M. Rahman, Y. Tamimi, Z. Al-Attabi, 2021 .

Epigenetic Status of FBXW7 Gene and Its Role in Ovarian Cancer Pathogenesis

A. Okamoto, I. Gupta, Y. Tamimi, 2023, Asian Pacific journal of cancer prevention : APJCP.